相关实验视频

Updated: May 7, 2025

Biosynthesis of a Flavonol from a Flavanone by Establishing a One-pot Bienzymatic Cascade

Biosynthesis of a Flavonol from a Flavanone by Establishing a One-pot Bienzymatic Cascade

Published on: August 14, 2019

一种来自Nothotsuga longibracteata树皮的新型双醇

Yi-Lin Wu¹, Min-Jian Dong¹, Cheng-Xin Sun¹

¹Key Laboratory of Basic Pharmacology of Guizhou Province and School of Pharmacy, Zunyi Medical University, Zunyi 563000, China.

Journal of Asian natural products research

|January 1, 2025

概括

研究人员从Nothotsuga longibracteata树皮中分离了七种黄衍生物. 这些化合物用DPPH和ABTS试验评估了它们的抗氧化特性.

科学领域:

自然产品化学自然产品化学
植物化学植物化学
药用化学医学化学

背景情况:

诺托苏加长甲虫 (Nothotsuga longibracteata) 的树皮是生物活性天然产品的潜在来源.
醇衍生物以其多样化的生物活动而闻名,包括抗氧化特性.

研究的目的:

从Nothotsuga longibracteata树皮中分离和表征醇衍生物.
评估分离化合物的抗氧化能力.

主要方法:

使用色谱技术分离化合物.
使用高分辨率电子喷雾电离质谱法 (HR-ESIMS),核磁共振 (NMR) 谱学和电子循环二元化 (ECD) 计算进行结构阐明.
抗氧化剂活性查使用DPPH (2,2-diphenyl-1-picrylhydrazyl) 和ABTS (2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)) 激素清除试验.

主要成果:

成功分离了七种黄衍生物:三种双黄 (1-3),两种黄 (4-5) 和两种螺旋黄 (6-7).
化合物1被确定为一种未经描述的新化合物.
通过光谱和计算方法证实了所有分离化合物的结构.
评估了所有孤立的黄醇衍生物的抗氧化潜力.

结论:

在Nothotsuga longibracteata树皮中含有丰富多样性的黄衍生物.
孤立的黄衍生物,包括新型化合物1,需要进一步研究它们的潜在治疗应用.
抗氧化剂查为了解这些化合物的潜在健康益处提供了基础.

关键词:

没有一条长长的长臂.抗氧化剂活性抗氧化剂活性这是一种双乙醇 (biflavanol).松树 (Pinaceae) 是一种松树.

更多相关视频

HKUST-1 as a Heterogeneous Catalyst for the Synthesis of Vanillin

HKUST-1 as a Heterogeneous Catalyst for the Synthesis of Vanillin

Published on: July 23, 2016

Preparation of Gynura bicolor DC samples for High-Resolution Tandem Mass Spectrometry

Preparation of Gynura bicolor DC samples for High-Resolution Tandem Mass Spectrometry

Published on: February 2, 2024

相关概念视频

Preparation of Diols and Pinacol Rearrangement

Preparation of Diols and Pinacol Rearrangement

Compounds bearing two hydroxyl groups are known as diols. When the hydroxyl groups are located on adjacent carbon atoms, the diols are called vicinal diols or glycols. Under acidic conditions, vicinal diols undergo a specific reaction called pinacol rearrangement.
The reaction begins with transferring a proton from the acid catalyst to one of the hydroxyl groups, producing an oxonium ion.

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...